Denosumab Is Superior to Raloxifene in Lowering Risks of Mortality and Ischemic Stroke in Osteoporotic Women
Both osteoporosis and cardiovascular disease (CVD) share similar pathways in pathophysiology and are intercorrelated with increased morbidity and mortality in elderly women. Although denosumab and raloxifene are the current guideline-based pharmacological treatments, their impacts on cardiovascular...
Saved in:
Main Authors: | Ting-Chun Liu (Author), Chien-Ning Hsu (Author), Wen-Chin Lee (Author), Shih-Wei Wang (Author), Chiang-Chi Huang (Author), Yueh-Ting Lee (Author), Chung-Ming Fu (Author), Jin-Bor Chen (Author), Lung-Chih Li (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of Adverse Kidney Outcomes With Empagliflozin and Linagliptin Use in Patients With Type 2 Diabetic Patients in a Real-World Setting
by: Yueh-Ting Lee, et al.
Published: (2021) -
Case series: Osteonecrosis of the jaw related to denosumab preceded by bisphosphonates in cancer and osteoporotic patients
by: Devie Falinda, et al.
Published: (2022) -
Pretreatment of Sialic Acid Efficiently Prevents Lipopolysaccharide-Induced Acute Renal Failure and Suppresses TLR4/gp91-Mediated Apoptotic Signaling
by: Shih-Ping Hsu, et al.
Published: (2016) -
Cost-Effectiveness of Sequential Denosumab/Zoledronic Acid Compared With Zoledronic Acid Monotherapy for Postmenopausal Osteoporotic Women in China
by: Ruxu You, et al.
Published: (2022) -
Significant improvement of bone mineral density by denosumab treatment in Japanese osteoporotic patients following breast cancer treatment
by: Nakamura Y, et al.
Published: (2018)